Cargando…

Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies

SIMPLE SUMMARY: Cutaneous side effects are among the most frequently reported adverse reactions of modern dermato-oncological therapies, such as immune checkpoint inhibitors and targeted therapies. This study aims to provide a detailed overview of the cutaneous toxicity profile of these treatments t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plachouri, Kerasia-Maria, Florou, Vaia, Georgiou, Vasileios, Georgiou, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296313/ https://www.ncbi.nlm.nih.gov/pubmed/37370736 http://dx.doi.org/10.3390/cancers15123126

Ejemplares similares

Virtual Dermatological Congresses: A Chance for Equality and Diversity in Continuous Medical Education
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2021)

Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2021)

A Rare Infectious Complication of a Treatment With Biologics: Disseminated Cutaneous Leishmaniasis Associated With Adalimumab
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2020)

Herpes Zoster Onset 9 Years After First Varicella Zoster Vaccination in an 11-year-old Child - A Case Report
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2019)

Nipple candidiasis and painful lactation: an updated overview
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2022)

Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Plachouri, Kerasia‐Maria, et al.
Publicado: (2021)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
por: Gullo, Giulia, et al.
Publicado: (2022)

Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2017)

Emerging mechanisms of immunotherapy resistance in sarcomas
por: Florou, Vaia, et al.
Publicado: (2022)

Comparison of intra-abdominal abscess formation after laparoscopic and open appendectomy for complicated and uncomplicated appendicitis: a retrospective study
por: Mulita, Francesk, et al.
Publicado: (2021)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction
por: Florou, Vaia, et al.
Publicado: (2021)

Modern Dermatology and Syphilology
por: Strauss, M.
Publicado: (1947)

Modern Dermatology and Syphilology
Publicado: (1947)

Modern Trends in Dermatology
Publicado: (1948)

Modern Dermatology and Syphilology
Publicado: (1943)

Green nail syndrome caused by Citrobacter braakii
por: Mulita, Francesk, et al.
Publicado: (2021)

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
por: Kroschinsky, Frank, et al.
Publicado: (2017)

Dermatologic Surgery and Dermatologic Oncology as an Essential Part of the Modern Dermatology in Bulgaria
por: Tchernev, Georgi, et al.
Publicado: (2017)

Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors
por: Cubero, Daniel I G, et al.
Publicado: (2018)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Role of Cutaneous Microbiome in Dermatology
por: Mustari, Akash P., et al.
Publicado: (2023)

Functional Properties of Amino Acid Side Chains as Biomarkers of Extraterrestrial Life
por: Georgiou, Christos D.
Publicado: (2018)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Cutaneous Signs in Dermatological Diseases; An Overview
por: Sharma, Surabhi, et al.
Publicado: (2021)

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
por: Costa Svedman, Fernanda, et al.
Publicado: (2022)

Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology
por: Dreno, B, et al.
Publicado: (2013)

Ocular Side Effects of Systemic Drugs Used in Dermatology
por: Prakash, Bhanu, et al.
Publicado: (2019)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

The need for kidney biopsy in the management of side effects of target and immunotherapy
por: Fenoglio, Roberta, et al.
Publicado: (2023)

Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
por: Lacouture, Mario, et al.
Publicado: (2018)

Cutaneous Conditions Leading to Dermatology Consultations in the Emergency Department
por: Jack, Alexander R, et al.
Publicado: (2011)

Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society
por: Hofmann, Heidelore, et al.
Publicado: (2017)

From ancient Egypt to the dermatologic office: An overview of skin substitutes and modern‐day applications in dermatologic surgery
por: Tran, Alison, et al.
Publicado: (2023)

Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
por: Myint, Zin W., et al.
Publicado: (2017)

Management of Dermatologic Toxicities Associated With Targeted Therapy
por: Lacouture, Mario E.
Publicado: (2016)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

The dark side of immunotherapy
por: Okwundu, Nwanneka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4bfsjb363s656kh0bkl9eeikur